Cargando…
Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients
OBJECTIVES: Creatinine is the biomarker of choice for use in estimates of kidney function in oncology patients. However as non-renal factors such as muscle mass can influence creatinine concentrations, we evaluated cystatin C as an alternative biomarker and its incorporation in GFR estimating formul...
Autores principales: | Jones, Melissa, Denieffe, Stephanie, Griffin, Ciara, Tinago, Willard, Fitzgibbon, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575377/ https://www.ncbi.nlm.nih.gov/pubmed/28856234 http://dx.doi.org/10.1016/j.plabm.2017.05.005 |
Ejemplares similares
-
Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012) -
GFR Estimation After Cystatin C Reference Material Change
por: Benoit, Stefanie W., et al.
Publicado: (2020) -
Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR
por: Wang, Yeli, et al.
Publicado: (2023) -
Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: A case report
por: Karawajczyk, Malgorzata, et al.
Publicado: (2008) -
Estimated GFR Accuracy When Cystatin C– and Creatinine-Based Estimates Are Discrepant in Older Adults
por: Potok, O. Alison, et al.
Publicado: (2023)